Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H30N6O3S2 |
Molecular Weight | 502.653 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OCCN2CCOCC2)C=C(C=C1)C3=NC([C@@H](C)SC4=NC(N)=CC(N)=N4)=C(C)S3
InChI
InChIKey=MFVINMPRHHUSBW-OAHLLOKOSA-N
InChI=1S/C23H30N6O3S2/c1-14-21(15(2)34-23-26-19(24)13-20(25)27-23)28-22(33-14)16-4-5-17(30-3)18(12-16)32-11-8-29-6-9-31-10-7-29/h4-5,12-13,15H,6-11H2,1-3H3,(H4,24,25,26,27)/t15-/m1/s1
Molecular Formula | C23H30N6O3S2 |
Molecular Weight | 502.653 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:04:47 GMT 2023
by
admin
on
Sat Dec 16 14:04:47 GMT 2023
|
Record UNII |
8EK0RD3M21
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
845721
Created by
admin on Sat Dec 16 14:04:47 GMT 2023 , Edited by admin on Sat Dec 16 14:04:47 GMT 2023
|
||
|
FDA ORPHAN DRUG |
792220
Created by
admin on Sat Dec 16 14:04:47 GMT 2023 , Edited by admin on Sat Dec 16 14:04:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8EK0RD3M21
Created by
admin on Sat Dec 16 14:04:47 GMT 2023 , Edited by admin on Sat Dec 16 14:04:47 GMT 2023
|
PRIMARY | |||
|
122491414
Created by
admin on Sat Dec 16 14:04:47 GMT 2023 , Edited by admin on Sat Dec 16 14:04:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|